These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 27342458)
1. Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment. Lazúrová I; Tomáš Ľ Clin Rev Allergy Immunol; 2017 Jun; 52(3):323-332. PubMed ID: 27342458 [TBL] [Abstract][Full Text] [Related]
2. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs]. Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922 [TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study. Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107 [TBL] [Abstract][Full Text] [Related]
4. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors. Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650 [TBL] [Abstract][Full Text] [Related]
5. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation. Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs. Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients. Rodríguez-Carrio J; Alperi-López M; López P; Ballina-García FJ; Abal F; Suárez A Transl Res; 2015 Dec; 166(6):529-39. PubMed ID: 26279255 [TBL] [Abstract][Full Text] [Related]
8. [Inflammation-related cardiovascular morbidity : Pathophysiology and therapy]. Fischer-Betz R; Halle M; Schneider M Z Rheumatol; 2010 Oct; 69(8):680-4, 686-8. PubMed ID: 20862480 [TBL] [Abstract][Full Text] [Related]
12. Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks. Zoli A; Bosello S; Comerci G; Galiano N; Forni A; Loperfido F; Ferraccioli GF Rheumatol Int; 2017 Jan; 37(1):13-19. PubMed ID: 26586235 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach. Jurcuţ C; Jurcuţ R; Tănăsescu C Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138 [TBL] [Abstract][Full Text] [Related]
14. Early markers of cardiovascular risk in chronic kidney disease. Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527 [TBL] [Abstract][Full Text] [Related]